Biological product deviation report (BPDR)
Biological product deviation report (BPDR) is a report as described in 600.14 and 606.171 of this chapter.
Source
21 CFR § 4.101
Scoping language
Abbreviated new drug application (ANDA) has the same meaning given the term abbreviated application in 314.3 of this chapter.